Peer Review History
| Original SubmissionJuly 16, 2020 |
|---|
|
PONE-D-20-22073 Public perceptions of conflicting information surrounding COVID-19: Results from a nationally representative survey of U.S. adults PLOS ONE Dear Dr. Nagler, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 21 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Sze Yan Liu, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please improving statistical reporting and refer to p-values as "p<.001" instead of "p=.000". Our statistical reporting guidelines are available at https://journals.plos.org/plosone/s/submission-guidelines#loc-statistical-reporting 3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. 4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review “Public perceptions of conflicting information surrounding COVID-19: results from a nationally representative survey of U.S. adults.” The article presents interesting and timely findings regarding whether the public notices conflicting COVID information, particularly between health experts and politicians, and correlates of perception of conflicting information. Abstract • Well-written Introduction • The introduction is well-written and presents relevant previous studies and a rationale for the current study. Methods • Define the acronym NORC • Recommend cutting the sentence on line 155 starting with, “as a multi-client.” Sounds like an unnecessary endorsement of NORC. • Can you note how long the total survey was so we can get an idea of how long the survey was and respondent burden? • Some of the conflicting information questions seem to be at a high level of literacy. For example, the definition of health experts is long and it is unlikely the general public knows what an “academic research institution” is. Were these questions piloted with individuals with low health literacy? If not, this should be noted as a limitation. • Why was social media left off as a source for COVID-19 info? • Line 277: please provide more detail about the regressions, including what the dependent variables were in the models. • Please state what level of significance was (alpha) Results • Line 304: since the means are between 2 and 3, can you present those response options rather than the 1 and 4 response options. Can you also comment on whether these data were skewed or kurtotic? • Line 311: please change p=.000 to p<0.001 • There are a lot of variables included in the regression- did you check for collinearity? • Have you thought about entering the number of sources as a variable in the model rather than listing cable news, national news, local news, etc, separately? Discussion • Nice discussion of motivated reasoning • Limitations should also mention that there were more Democrats and well-educated respondents in the sample and how this may affect the results Reviewer #2: This is a very well written article dealing with a delicate topic. The paper presents the data of nationally representative surveys and study design and statistical analyses are strong. Thus, it appeal to readers' interest and/or help to understand the impact of conflicting information surrounding COVID-19 abounds on non-pharmaceutical intervention. Thanks for your outstanding contributions. Reviewer #3: The purpose of this study was to examine perceptions of conflicting information from both health experts and politicians about COVID-19 among a nationally representative sample of slightly over 1,000 U.S. adults. Data were collected in late April 2020. Three-quarters of respondents reported being exposed to conflicting information, and the authors report demographic and other characteristics associated with perceptions of conflicting information. The study is primarily descriptive and is not hypothesis-driven. I enjoyed reading this paper and found the information to have great implications for health communication strategies surrounding COVID-19. The introduction does a very nice job of situating this study in the existing literature on conflicting health information. Strengths of the paper include a thorough and succinct introduction, national sampling procedures, counter balancing of measures (i.e. when measures were duplicated about health experts and politicians), and a strong discussion section. The methods and analyses are largely solid. As the authors note in the abstract, it will be important to understand how these beliefs are associated with cognitive and behavioral outcomes, and it is unfortunate that measures of that type were not included in this paper. I describe minor suggestions for improving the paper. Introduction 1. Do the findings of this study have implications beyond understanding COVID? This could be addressed more in the intro and/or discussion. 2. Page 5, line 97: “what seem like daily swings in recommendations” sounds subjective and I think different terminology might be used to emphasize the frequency without this language. 3. I had difficulty understanding the definition of the politicization of health issues (pg 6, lines 122-123). An example might help to clarify. Materials and Methods 4. For transparency, could the authors describe the other measures that were included in the survey but that are not analyzed here? 5. More of a description/explanation about NORC would be helpful. For example, what exactly does it mean that the panel “provides sample coverage of approximately 97% of the U.S. household population”? Could this be stated in more plain language? Also, how big is the panel, and do panel members complete multiple surveys? 6. Four summary indices of perceptions of conflicting information are reported. What is the justification for keeping these separate rather than combining all the items referring to health experts and all of those referring to politicians (for a total of two scales)? I would like to see the alphas of the scales and correlations among the scales. 7. Additional justification is needed for how the specific news sources were collapsed into the categories of cable news, national news, etc. I would think that the sources categorized as cable news tend to be more conservative than those classified as national news, which is a potential limitation/confound of the categories reported. I am not sure how meaningful the categories are as reported. I would imagine that relying on different news sources differs by political affiliation in meaningful ways, and the authors might consider accounting for this in their analyses. Discussion 8. I was unclear what the sentence starting with “By comparison…” (page 23, lines 392-395) meant. 9. Please add citations to the statement that theory and research on the effects of exposure to conflicting health information raise cause for concern (page 25, lines 439-440). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-22073R1 Public perceptions of conflicting information surrounding COVID-19: Results from a nationally representative survey of U.S. adults PLOS ONE Dear Dr. Nagler, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As noted by the reviewers' the authors did an excellent job responding to earlier concerns. There are two minor suggestions that we would like to authors to add to the manuscript to further strengthen it. Please submit your revised manuscript by Nov 13 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Sze Yan Liu, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors did an excellent job responding to reviewer comments. I look forward to seeing this published. Reviewer #3: The authors were very responsive to the reviews and have improved the manuscript. I just have two minor additional comments related to issues that were addressed in the response to the reviewers but that I believe could be addressed more directly in the manuscript. First, the authors state that some of the data not reported here are reported in a separate manuscript (Reviewer #3, Point 4). For transparency, I think the authors should cite the other paper (even if still in preparation or under review) and briefly describe the content so that reviewers/readers can be confident that the papers do not overlap. Second, the authors describe the conceptual distinction between aspects and strategies related to COVID-19 in the letter (Reviewer #3, Point 6), but I did not see this described in the manuscript. I would recommend adding the justification from the letter to the manuscript, and perhaps including the correlations between the scales as well, in order to justify this decision to the reader. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Public perceptions of conflicting information surrounding COVID-19: Results from a nationally representative survey of U.S. adults PONE-D-20-22073R2 Dear Dr. Nagler, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sze Yan Liu, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-22073R2 Public perceptions of conflicting information surrounding COVID-19:Results from a nationally representative survey of U.S. adults Dear Dr. Nagler: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sze Yan Liu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .